tiprankstipranks
pc:mirad

Mirador Therapeutics

Mirador Therapeutics is a clinical-stage precision medicine company developing next-generation therapeutics for immune-mediated inflammatory and fibrotic diseases, including Crohn's disease, ulcerative colitis, rheumatoid arthritis, and idiopathic pulmonary fibrosis. The company leverages its Mirador360 precision discovery and development engine, which uses millions of patient profiles and advanced machine learning to support target discovery, patient stratification, and combination prioritization.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$250M
Total Amount Raised$250M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$250M
Latest Funding Amount$250M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 12, 2026
Series B
$250.00M

Investors

Investor Name
Funding Round

Related News and Analysis